AI assistant
Sending…
Sleep Number Corp — Director's Dealing 2021
Mar 3, 2021
33589_dirs_2021-03-03_73461fd6-75bb-49a7-a4cf-161903f58830.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Sleep Number Corp (SNBR)
CIK: 0000827187
Period of Report: 2021-03-01
Reporting Person: Poirier Robert Joseph (VP, CAO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-01 | Common Stock | M | 733 | $23.61 | Acquired | 1901 | Direct |
| 2021-03-01 | Common Stock | M | 511 | $34.35 | Acquired | 2412 | Direct |
| 2021-03-01 | Common Stock | M | 392 | $47.00 | Acquired | 2804 | Direct |
| 2021-03-01 | Common Stock | S | 1636 | $143.09 | Disposed | 1168 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-01 | Employee Stock Option (Right to Buy) | $23.61 | M | 733 | Disposed | 2027-03-21 | Common Stock (733) | Direct |
| 2021-03-01 | Employee Stock Option (Right to Buy) | $34.35 | M | 511 | Disposed | 2028-03-21 | Common Stock (511) | Direct |
| 2021-03-01 | Employee Stock Option (Right to Buy) | $47.00 | M | 392 | Disposed | 2029-03-29 | Common Stock (392) | Direct |
Footnotes
F1: Includes 1,168 shares from Restricted Stock Unit awards that vest over time.
F2: This option grant is fully vested and exercisable.
F3: This option becomes exercisable with respect to 1/3 of the shares on each of 3/21/19, 3/21/20 and 3/21/21.
F4: This option becomes exercisable with respect to 1/3 of the shares on each of 3/29/20, 3/29/21 and 3/29/22.
More from Sleep Number Corp
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
May 6
Regulatory Filings
2026
Apr 28
Proxy Solicitation & Information Statement
2026
Apr 8
Major Shareholding Notification
2026
Mar 27
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 23
Director's Dealing
2026
Mar 18